Two Sigma Investments, LP Catalyst Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 159,305 shares of CPRX stock, worth $3.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

159,305

Holding current value

$3.44 Million

% of portfolio

0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.19 - $21.35 $2.42 Million - $3.4 Million	159,305 New	159,305 $3.17 Million
Q2 2023 Aug 14, 2023	SELL	$11.5 - $18.08 $13.3 Million - $21 Million	-1,159,025 Reduced 97.86%	25,400 $341,000
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $10.6 Million - $15.6 Million	-740,665 Reduced 38.47%	1,184,425 $19.6 Million
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $2.33 Million - $3.71 Million	190,367 Added 10.97%	1,925,090 $35.8 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $8.98 Million - $19.7 Million	1,271,398 Added 274.41%	1,734,723 $22.3 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $8.57 $3.81 Million - $5.24 Million	-611,957 Reduced 56.91%	463,325 $3.25 Million
Q1 2022 May 16, 2022	BUY	$5.31 - $8.31 $1.67 Million - $2.61 Million	314,203 Added 41.28%	1,075,282 $8.91 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $3.37 Million - $4.82 Million	646,508 Added 564.29%	761,079 $5.15 Million
Q3 2021 Nov 15, 2021	SELL	$4.85 - $6.04 $1.12 Million - $1.4 Million	-231,494 Reduced 66.89%	114,571 $607,000
Q2 2021 Aug 16, 2021	SELL	$4.29 - $6.05 $1.01 Million - $1.42 Million	-235,188 Reduced 40.46%	346,065 $1.99 Million
Q1 2021 May 17, 2021	BUY	$3.45 - $4.69 $732,027 - $995,133	212,182 Added 57.49%	581,253 $2.68 Million
Q4 2020 Feb 16, 2021	BUY	$2.97 - $3.83 $1.1 Million - $1.41 Million	369,071 New	369,071 $1.23 Million
Q3 2020 Nov 16, 2020	SELL	$2.97 - $5.08 $1.27 Million - $2.17 Million	-426,197 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.48 - $5.05 $1.44 Million - $2.09 Million	413,126 Added 3160.63%	426,197 $1.97 Million
Q1 2020 May 15, 2020	SELL	$2.61 - $5.21 $1.83 Million - $3.65 Million	-699,686 Reduced 98.17%	13,071 $50,000
Q4 2019 Feb 14, 2020	BUY	$3.67 - $5.7 $2.62 Million - $4.06 Million	712,757 New	712,757 $2.67 Million
Q1 2019 May 15, 2019	SELL	$2.11 - $5.33 $297,518 - $751,551	-141,004 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.92 - $3.62 $270,727 - $510,434	141,004 New	141,004 $271,000
Q3 2018 Nov 14, 2018	SELL	$2.81 - $3.78 $60,901 - $81,923	-21,673 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$2.26 - $3.84 $42,268 - $71,819	-18,703 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.39 - $4.01 $928,448 - $1.56 Million	-388,472 Reduced 95.41%	18,703 $45,000
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $1.02 Million - $1.79 Million	407,175	407,175 $1.59 Million

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.22B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Catalyst Pharmaceuticals, Inc. Transaction History